When Space Activities Meet Food Law

As a food lawyer engaged with space law and the EU Space Act, I have been examining concrete regulatory intersections between space activities and EU food and biotechnology law. Two examples illustrate why this interface deserves some attention (or, at least, curiosity).

Space Breeding & Space Mutagenesis

Space breeding (or space mutagenesis) exploits cosmic radiation, microgravity, vacuum and altered geomagnetic conditions to accelerate random mutagenesis in seeds and plants. Mutation frequency increases significantly compared to spontaneous terrestrial mutation, while relying solely on the organism’s own genetic material and without transgenesis.

The technique “mimics” natural mutation, but at an amplified scale and intensity. It has generated higher-yield, disease-resistant, and early-maturing varieties. 

China has conducted space breeding since 1987, reporting over 3,000 experiments and more than 260 crop varieties, including “space rice” and “space lotus.”

The regulatory implications under EU law are not straightforward.

Directive 2001/18/EC on the deliberate release of Genetically Modified Organisms (GMO), Regulation (EU) No 1829/2003 on Genetically Modified Foods and Feeds, and Directive 2009/41/EC on the contained use of Genetically Modified Microorganisms (GMM) were all designed for terrestrial biotechnology.

Traditional mutagenesis benefits from an exemption under Directive 2001/18/EC, where techniques have a long safety record (CJEU C-528/16 and C-688/21), but whether space mutagenesis qualifies as “traditional” remains legally uncertain.

Microgravity Biomanufacturing: From Pharma to Food

For two decades, the ISS has hosted protein crystallisation in microgravity: more uniform crystals, fewer defects, improved bioavailability and shelf-life. Studies on albumin and lysozyme confirmed these advantages. Microgravity also enables study of cellular behavior, tissue growth, 3D cell cultures, aging processes, and stem cell proliferation.

If microgravity improves pharmaceutical protein crystallisation, the same could apply to food-grade enzymes, proteins, and food ingredients.

As commercial stations replace the ISS after 2030, food manufacturing in orbit becomes plausible.

Regulation (EU) No 2015/2283 is directly relevant: food produced using processes not used before 1997 qualifies as novel food, triggering EFSA risk assessment for variables with no terrestrial precedent.

Key Takeaways

With the boom in the space economy and private investment in space technologies, core regulatory issues emerge: applicable law, jurisdiction, interaction between EU food law and the future EU Space Act, and adaptation of risk assessment methodologies to extra-terrestrial manufacturing environments.

Space is becoming a production environment. This will redefine the boundaries of both food law and space law.